ong term effect of definitive chemoradiotherapy on respiratory function tests in patients with locally advanced (non)-small cell lung carcinoma

Withdrawn

• Conditions: (N)SCLC; lungcancer; 10029107

• Registration Number: NL-OMON53171
• Lead Sponsor: HagaZiekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

1.* 18 years of age
2.Histologically of cytologically confirmed diagnosis of (N)SCLC
3.Stage II/III non operable disease
4.Treatment with definite concurrent of sequential chemoradiation between November 2010 and November 2015
5.Lung function testing including DLCO measurement pre-treatment is available
6.Signed written informed consent

Exclusion Criteria

Not being able to have another lung function test done (due to death or poor condition)

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Change in FEV1 and DLCO >1 year after treatment with radiotherapy or<br /><br>combination treatment with chemoradiotherap either concurrent or sequential.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable</p><br>